CHINA WANTIAN (01854) signs a strategic cooperation agreement with Hengyang Jisuo focusing on AI-driven exoskeletons Siasun Robot & Automation and intelligent medical solutions.

China Wantian (01854) announced that on July 18, 2026, its indirectly wholly-owned subsidiary Shenzhen Wantian Artificial Intelligence Technology Co., Ltd. (Wantian Artificial Intelligence) and Hengyang Jisuo Medical Technology Co., Ltd. (Hengyang Jisuo) have entered into a strategic cooperation framework agreement (Strategic Framework Agreement) in the field of AI-driven exoskeleton Siasun Robot&Automation products and smart medical solutions. After conducting all reasonable inquiries, the Board of Directors is aware, fully informed, and convinced that Hengyang Jisuo and its ultimate beneficial owners are independent third parties separate from the Company and its related parties. The strategic cooperation between Wantian Artificial Intelligence Technology and Hengyang Jisuo aims to leverage each other's complementary advantages in commercializing and applying medical and consumer-grade exoskeleton Siasun Robot&Automation products. Hengyang Jisuo possesses advanced exoskeleton Siasun Robot&Automation technology and product development capabilities, while Wantian Artificial Intelligence Technology has strengths including access to a vast amount of industry resources brought by the Company and strong market capabilities. It is anticipated that this cooperation will provide various application scenarios for the commercialization of Siasun Robot&Automation technology. According to the Strategic Framework Agreement, Wantian Artificial Intelligence Technology and Hengyang Jisuo will mainly leverage their respective strengths and capabilities in the following four areas to drive the cooperation: (i) Product supply and technical cooperation - Hengyang Jisuo will prioritize providing exoskeleton Siasun Robot&Automation products, smart medical and health solutions, and related technical support services to Wantian Artificial Intelligence Technology and its affiliated entities. Wantian Artificial Intelligence Technology will utilize its industry resources and market capabilities to promote the application of these products in various commercial scenarios; (ii) Marketing and brand cooperation - Both parties will jointly carry out marketing and promotion activities. Hengyang Jisuo will provide product technical support and industry application cases, while Wantian Artificial Intelligence Technology will provide channel resources, brand promotion, and commercial operation support. Both parties plan to establish a new brand in the field of exoskeleton Siasun Robot&Automation technology and smart medical rehabilitation; (iii) Application scenario implementation and solution development - Both parties will collaborate to develop comprehensive solutions based on exoskeleton Siasun Robot&Automation technology, focusing on application scenarios such as cultural and tourist attractions, large commercial complexes, smart parks, commercial buildings, and medical rehabilitation institutions. Wantian Artificial Intelligence Technology will leverage its channel advantage and business resources to support the large-scale sales and operation of these solutions; and (iv) Business model exploration - Both parties will explore diversified business models, including product sales, attraction rental services, rehabilitation and health experience services, and operation and maintenance value-added services, to accelerate the market penetration and commercialization of exoskeleton Siasun Robot&Automation products. The Board of Directors believes that the strategic cooperation under the Strategic Framework Agreement provides the Group with the opportunity to expand its presence in the AI and Siasun Robot&Automation industries, especially in the rapidly growing exoskeleton Siasun Robot&Automation market. This cooperation is expected to facilitate the commercialization and large-scale implementation of exoskeleton technology in multiple industries and usage scenarios, further supporting the strategic integration of technology-related elements into the Company's existing business segments to optimize its operations. Therefore, the Board of Directors deems it appropriate to enter into the Strategic Framework Agreement in line with the Group's long-term business development strategy and in the overall interests of the Company and its shareholders.